Lyell Immunopharma, Inc., a clinical-stage cell therapy company, develops chimeric antigen receptor (CAR) T-cell product candidates for patients with hematologic malignancies and solid tumors. The company's lead product candidate include ro...
Leadership
Richard D. Klausner M.D.Founder
Founder & Executive Chairman
Lynn Seely M.D., Ph.D.
Principal Executive Officer, President, CEO & Director
Stephen J. Hill
Chief Operating Officer
Gary K. Lee Ph.D.
Chief Scientific Officer
Stanley R. Riddell M.D.Founder
Founder & Scientific Advisor
Crystal L. Mackall M.D.Founder
Founder & Scientific Advisor
Smital Shah M.B.A.
Principal Financial Officer, CFO & Chief Business Officer
